-
CIFC LLC (NASDAQ: CIFC) shares climbed 58.9
percent to $10.98 after the company agreed to be acquired by F.A.B. Partners for $333 million in cash.
-
RLJ Entertainment Inc (NASDAQ: RLJE) shares
gained 58.2 percent to $3.10. RLJ Entertainment shares have climbed 67.44 percent over the past 52 weeks, while the S&P 500
index has gained 15.35 percent in the same period.
-
StemCells Inc (NASDAQ: STEM) shares rose 43.6
percent to $1.78. StemCells shares have dropped 72.81 percent over the past 52 weeks, while the S&P 500 index has gained
15.35 percent in the same period.
-
Lantronix Inc (NASDAQ: LTRX) gained 24.8 percent
to $1.60. Lantronix reported the launch of a new premier partner program, Lantronix SmartAdvantage. The company is expected to
report its Q4 financial results on August 23, 2016.
-
Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC)
shares rose 23 percent to $8.52. Tang Capital Partners disclosed a 9.6 percent passive stake in Cyclacel Pharmaceuticals,
according to a regulatory filing.
-
Medivation Inc (NASDAQ: MDVN) shares surged 19.7
percent to $80.41. Pfizer Inc (NYSE: PFE) and
Medivation struck a definitive deal through which the former would buy the latter for $81.50 a share in cash.
-
Intersil Corp (NASDAQ: ISIL) shares gained 19.6
percent to $18.71 following a report it was near a deal to be acquired by Renesas Electronics for up to $2.99 billion.
-
Syngenta AG (ADR) (NYSE: SYT) gained 10.3 percent to
$87.73 after a U.S. national security panel cleared its acquisition by ChemChina.
-
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) rose
8.1 percent to $31.07. Valeant Pharma named Paul Herendeen as new CFO.
-
Cardiovascular Systems Inc (NASDAQ: CSII) gained
4.8 percent to $23.69. Leerink Swann upgraded Cardiovascular Systems from Market Perform to Outperform.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.